Symposia: Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Bleeding and Clotting, bleeding disorders, Biological therapies, Anticoagulant Drugs, clinical trials, adult, Clinical Practice (Health Services and Quality), Non-Biological therapies, hemophilia, epidemiology, elderly, Clinical Research, health outcomes research, pediatric, Diseases, Therapies, real-world evidence, VWD, Adverse Events, young adult , Study Population, Human
Type: Oral
Hematology Disease Topics & Pathways:
Research, Bleeding and Clotting, bleeding disorders, Biological therapies, Anticoagulant Drugs, clinical trials, adult, Clinical Practice (Health Services and Quality), Non-Biological therapies, hemophilia, epidemiology, elderly, Clinical Research, health outcomes research, pediatric, Diseases, Therapies, real-world evidence, VWD, Adverse Events, young adult , Study Population, Human
Sunday, December 11, 2022: 4:30 PM-6:00 PM
288-290
(Ernest N. Morial Convention Center)
Moderators:
Jill M. Johnsen, MD, University of Washington
and
Alice Ma, MD, University of North Carolina At Chapel Hill
Disclosures:
Johnsen: Octapharma: Consultancy, Honoraria, Research Funding; CSL Behring: Consultancy, Honoraria; Takeda: Consultancy, Honoraria. Ma: Takeda: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees.
This session will focus on other hemorrhagic disorders, both congenital and acquired. Topics include Prevalence, diagnosis, therapies, and complications of treatment.
4:30 PM
4:45 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH